TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis.
Vaccines (Basel). 2017 Oct 4;5(4):34. doi: 10.3390/vaccines5040034.
Vaccines (Basel). 2017.
PMID: 28976923
Free PMC article.
Review.